Immunotherapy with a calcium phosphate-adsorbed five-grass-pollen extract in seasonal rhinoconjunctivitis: A double-blind, placebo-controlled study

Clinical and Experimental Allergy

Volumn 31, Issue 7, 2001, Pages 988-996

  Leynadier, F ^a   Banoun, L ^b   Dollois, B ^b   Terrier, P ^b   Epstein, M ^b   Guinnepain, M T ^c   Firon, D ^b   Traube, C ^b   Fadel, R ^d   André, Claude ^d  

^a HÔPITAL ROTHSCHILD   (France)

^b Hôpital Pasteur ^*

^c Service des Vaccinations   (France)

^d Stallergenes SA   (France)

Author keywords

Allergic rhinitis; Grass pollen; Nasal provocation test; Skin prick test; Specific IgE; Specific IgG4; Specific immunotherapy

Indexed keywords

CALCIUM PHOSPHATE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4;

ADULT; ANTIBODY RESPONSE; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; FEMALE; GRASS POLLEN; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; RHINOCONJUNCTIVITIS; SKIN MANIFESTATION;

EID: 0034832166     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01145.x     Document Type: Article

References (27)

1. Immunotherapy as an effective tool in allergy treatment
2. Allergen immunotherapy: Therapeutic vaccines for allergic diseases
3. Grass pollen immunotherapy: A single year double-blind, placebo-controlled study in patients with grass-pollen-induced asthma and rhinitis
4. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs
5. Preparation and use of calcium phosphate adsorbed vaccines
6. Calcium phosphate adjuvanted allergens
7. Persistent subcutaneous nodules in children hyposensitized with aluminium precipitated grass pollen
8. Calcium phosphate adjuvanted allergens: Total and specific IgE levels before and after immunotherapy with house dust and Dermatophagoides pteronyssinus extracts
9. Désensibilisation par des extraits de pollen adsorbés sur phosphate de calcium pendant 4 années consécutives: Étude des sérums par immunoempreintes, RAST et PRIST
10. Tolerancia de la immunoterapia especifica con extractos alergenicos adsorbidos sobre fosfato de calcio
11. Tolérance, compliance et efficacité de l'immunothérapie spécifique par des extraits allergéniques aqueux ou adsorbés sur phosphate de calcium. Etude rétrospective
12. Immunotherapy (position paper)
13. Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains
14. Proposed guidelines for quantitative skin prick test procedures to determine the biological activity of allergenic extracts using parallel line assay
15. Immunotherapy with grass pollen major allergens. Immunological results from a prospective 3-year double blind study
16. Clinical and immunological effects of immunotherapy with alum-absorbed grass allergoid in grass-pollen-induced hay fever
17. Grass pollen immunotherapy: Efficacy and safety during a 4-year follow-up study
18. A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract Alutard SQ during a 3-year period with initial rush immunotherapy
19. Long-term clinical efficacy of grass-pollen immunotherapy
20. Responses to ragweed-pollen nasal challenge before and after immunotherapy
21. Allergic rhinitis to ragweed pollen. I. Reassessment of the effects of immunotherapy on cellular and humoral responses
22. Mediator release after nasal airway challenge with allergen
23. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts
24. Grass pollen immunotherapy decreases the number of mast cells in the skin
25. The role of IgG subclass antibodies in the clinical response to immunotherapy in allergic disease
26. Late and immediate systemic-allergy reactions to inhalant allergen immunotherapy
27. Systemic reactions from allergen immunotherapy